Related Experiment Videos
Schistosoma mansoni genome project: an update
Philip T LoVerde1, Hirohisa Hirai, Joseph M Merrick
1Department of Microbiology and Immunology, State University of New York, Buffalo, NY 14214, USA. loverde@buffalo.edu
Parasitology International
|April 15, 2004
Summary
The Schistosoma mansoni genome project aims to discover new drug and vaccine targets. Genome sequencing and functional genomics will accelerate schistosomiasis control strategies.
Area of Science:
- Genomics
- Parasitology
- Molecular Biology
Background:
- The Schistosoma mansoni genome project, initiated in 1994 by the World Health Organization, focuses on gene discovery and analysis.
- Schistosoma mansoni possesses a haploid genome of 270 Mb across 8 chromosome pairs, estimated to contain 15,000-25,000 genes.
- Over 16,000 expressed sequence tags (ESTs) are available, but more than half represent genes of unknown function, with only 20-25% of total schistosome genes discovered.
Purpose of the Study:
- To identify novel drug, vaccine, and diagnostic targets for schistosomiasis.
- To advance the understanding of the Schistosoma mansoni genome and its functional elements.
- To accelerate the development of effective schistosomiasis control and treatment strategies.
Main Methods:
- Initiation of a genome project involving gene discovery, chromosome mapping, and whole genome sequencing.
- Analysis of expressed sequence tags (ESTs) from diverse S. mansoni developmental stages.
- Genome sequencing program aiming for 3X coverage to achieve 95% gene discovery.
Main Results:
- Current EST data indicates a significant proportion of genes with unknown functions.
- Approximately 20-25% of total schistosome genes are estimated to have been discovered to date.
- Low-resolution chromosome mapping efforts are ongoing.
Conclusions:
- The genomics era provides tools for functional genomics, including microarrays and proteomics.
- Functional genomics will enable detailed study of parasite pathways, protein interactions, and metabolic pathways.
- Accelerated development of schistosomiasis interventions is anticipated through these genomic approaches.